BlackRock Fund Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History

BlackRock Fund Advisors’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.23M	Buy	22,784 +3,015	+15%	+$282K	﹤0.01%	3148
2016 Q3	$1.97M	Buy	19,769 +5,685	+40%	+$594K	﹤0.01%	3163
2016 Q2	$1.73M	Buy	14,084 +12,647	+880%	+$1.69M	﹤0.01%	3214
2016 Q1	$184K	Sell	1,437 -119	-8%	-$9.62K	﹤0.01%	3497
2015 Q4	$72K	Buy	1,556 +892	+134%	+$75.5K	﹤0.01%	3810
2015 Q3	$64K	Sell	664 -18	-3%	-$2.13K	﹤0.01%	3783
2015 Q2	$93K	Buy	682 +82	+14%	+$13.1K	﹤0.01%	3749
2015 Q1	$107K	Buy	600 +406	+209%	+$70.6K	﹤0.01%	3611
2014 Q4	$39K	Buy	+194	New	+$34.9K	﹤0.01%	3685
2014 Q2	–	Sell	-4,908	Closed	-$982K	–	3991
2014 Q1	$982K	Buy	+4,908	New	+$982K	﹤0.01%	3192

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Fund Advisors's ARGS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Argos Therapeutics, Inc. (ARGS) stake by 15% in Q4 2016, buying an estimated $282K and bringing the position to 22,784 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3148.

BlackRock Fund Advisors first reported a position in ARGS in Q1 2014 and has held it in 10 quarters since. 52 funds tracked by Wall St. Rank hold ARGS as of Q4 2016.

BlackRock Fund Advisors held 22,784 shares of Argos Therapeutics, Inc. worth $2.23M as of Q4 2016.
BlackRock Fund Advisors bought 3,015 Argos Therapeutics, Inc. shares in Q4 2016, an estimated $282K.
Argos Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3148 holding.
BlackRock Fund Advisors first reported a position in Argos Therapeutics, Inc. in Q1 2014 and has held it in 10 quarters since.
52 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.